New Drugs of 2017 (Home Study)

Activity Preview

Stay up to date on all the new medications approved and first marketed in 2017, including their indications for use, routes of administration, and associated precautions. Get an overview of each new agent and its role in therapy. Is newer better? Comparisons with pre-existing agents will be discussed, as applicable. You’ll also get tips on patient education and practical information on monitoring.

Activity Type: Knowledge-based
Target Audience: Pharmacists and Pharmacy Technicians
Learning Level: Level 1

Learning Objectives

At the completion of this activity, the pharmacist and technician will be able to:

List new therapeutic agents that were approved by the U.S. Food and Drug Administration and first marketed during 2017.
Describe the mechanisms of action and indications for new therapeutic agents first marketed in 2017.
Summarize adverse effects and patient safety considerations for new therapeutic agents first marketed in 2017.
Compare new therapeutic agents first marketed in 2017 with other available therapeutic options.

Accreditation Information

The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education (CPE). The following webinar is approved for 1.5 contact hours of CPE credit (0.15 CEUs). The ACPE Universal Activity Numbers for this activity is 0202-0000-18-196-H01-P/T.

To obtain credit for attending New Drugs of 2017 (Home Study), participants must complete the assessment with a grade of 70% or better, complete the evaluation, and then claim credit. Participants must have a valid pharmacist.com username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.

Initial Release Date: August 17, 2018

Expiration Date: August 17, 2021

Development

New Drugs of 2017 (Home Study) is a home-study continuing education activity for pharmacists and pharmacy technicians developed by the American Pharmacists Association.

Support

This activity is supported by an independent educational grant from Janssen Scientific Affairs.

Disclosures

Daniel Hussar, BSPharm, MS, PhD, and APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, please visit the APhA website at www.pharmacist.com/apha-disclosures .

Conflicts of interest have been resolved through content review by Helen Sairany, PharmD, BCACP, Associate Director of Content Development at the American Pharmacists Association.

Activity Fee

There is no fee for this live activity.

System Requirements

Computer and internet access are required to complete this activity. Please visit our website to view the System Requirements in order to have a positive learning experience.

Credit Information

Activity Number	Credit Amount	Accreditation Period
ACPE# 0202-0000-18-196-H01-P	0.15 CEUs	August 17, 2018 - August 17, 2021
ACPE# 0202-0000-18-196-H01-T	0.15 CEUs	August 17, 2018 - August 17, 2021

Instructor

Daniel Hussar, PhD Instructor

Daniel A. Hussar is the Remington Professor of Pharmacy at the Philadelphia College of Pharmacy at the University of the Sciences in Philadelphia. He is a member of a number of professional organizations including the American Pharmacists Association, American Society of Health-system Pharmacists, Drug Information Association, and the Pennsylvania Pharmacists Association. He has served as a member of the Board of Trustees and as Honorary President of the American Pharmacists Association, and is a Past President of the Drug Information Association and the Pennsylvania Pharmacists Association. He has served on the Board of Directors of World Vision and the Board of Directors of Christian Pharmacists Fellowship International. Dr. Hussar teaches the Nonprescription Therapeutics course and coordinates the Pharmacy Law and Ethics course at the Philadelphia College of Pharmacy. His primary interests are in the areas of new drugs, drug interactions, and issues facing the profession of pharmacy, and he has written and spoken extensively on these subjects. For many years he has published articles in several professional journals on the new medications that have been marketed in the United States, and he is the author of the book, New Drugs (2008-2012) and Comparison Ratings. He serves as the Author/Editor of The Pharmacist Activist newsletter.
Other products with this instructor

Log Out